JPH07503252A - 置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法 - Google Patents

置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法

Info

Publication number
JPH07503252A
JPH07503252A JP5513407A JP51340793A JPH07503252A JP H07503252 A JPH07503252 A JP H07503252A JP 5513407 A JP5513407 A JP 5513407A JP 51340793 A JP51340793 A JP 51340793A JP H07503252 A JPH07503252 A JP H07503252A
Authority
JP
Japan
Prior art keywords
compound
carbon atoms
formula
composition
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5513407A
Other languages
English (en)
Japanese (ja)
Inventor
バッジャー,アリソン・メアリー
Original Assignee
スミスクライン・ビーチャム・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・コーポレイション filed Critical スミスクライン・ビーチャム・コーポレイション
Publication of JPH07503252A publication Critical patent/JPH07503252A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP5513407A 1992-01-28 1993-01-27 置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法 Pending JPH07503252A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9201803.5 1992-01-28
GB929201803A GB9201803D0 (en) 1992-01-28 1992-01-28 Methods
PCT/US1993/000730 WO1993014760A2 (fr) 1992-01-28 1993-01-27 Procedes

Publications (1)

Publication Number Publication Date
JPH07503252A true JPH07503252A (ja) 1995-04-06

Family

ID=10709398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5513407A Pending JPH07503252A (ja) 1992-01-28 1993-01-27 置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法

Country Status (7)

Country Link
EP (1) EP0624089A4 (fr)
JP (1) JPH07503252A (fr)
KR (1) KR950700068A (fr)
AU (1) AU666175B2 (fr)
CA (1) CA2128535A1 (fr)
GB (1) GB9201803D0 (fr)
WO (1) WO1993014760A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007537251A (ja) * 2004-05-12 2007-12-20 ブリストル−マイヤーズ スクイブ カンパニー Hivインテグラーゼ阻害剤:環状ピリミジノン化合物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US181704A (en) * 1876-08-29 Improvement in flour-dressing machines
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
JPH06501468A (ja) * 1990-09-24 1994-02-17 スミスクライン・ビーチャム・コーポレイション 方法
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007537251A (ja) * 2004-05-12 2007-12-20 ブリストル−マイヤーズ スクイブ カンパニー Hivインテグラーゼ阻害剤:環状ピリミジノン化合物

Also Published As

Publication number Publication date
WO1993014760A3 (fr) 1993-09-02
GB9201803D0 (en) 1992-03-11
AU666175B2 (en) 1996-02-01
KR950700068A (ko) 1995-01-16
EP0624089A1 (fr) 1994-11-17
WO1993014760A2 (fr) 1993-08-05
AU3595193A (en) 1993-09-01
CA2128535A1 (fr) 1993-08-05
EP0624089A4 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
JP3133345B2 (ja) Hivに対して活性な連結環状ポリアミン
JP2904827B2 (ja) 不安および不安抑うつ障害の処置に有用な医薬組成物の調製へのトリフルオロメチルフェニルテトラヒドロピリジンの使用
JP2000517323A (ja) B型肝炎およびレトロウイルス関連疾患の治療のためのジカフェオイルキナ酸の新規使用および新規カフェオイルキナ酸誘導体
AU614515B2 (en) A pharmaceutical combination for the prophylaxis and therapy of malaria
JPS63310819A (ja) 抗レトロウイルス活性をもつ糖タンパク処理抑制剤
JPH0232093A (ja) 抗レトロウィルスジフルオロ化ヌクレオシド類
IL96618A (en) Pharmaceutical preparations containing a history of fluoroquinolones for the treatment of pneumocystosis
JPH07503252A (ja) 置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法
US5519028A (en) Antiviral preparations
JPH0521891B2 (fr)
JP2013517262A (ja) 抗エイズ剤としての多環式化合物の医薬的使用
EP0713391A1 (fr) Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues
US5482959A (en) Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
WO1995003042A1 (fr) Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues
JPH09500646A (ja) アザスピランによるhivの治療法
WO1992016200A1 (fr) Utilisation de derives d'acide hydroxamique pour l'inhibition de la replication virale
JPH04108731A (ja) 抗エイズウイルス剤
JPH09500647A (ja) 置換アザスピランによるヒト免疫不全ウイルス産生の阻害法
CZ367598A3 (cs) Použití substituovaného azaspiranu
AU684384B2 (en) Method of treating opportunistic infections with azaspiranes
WO2011046901A2 (fr) Antiviral à large spectre et procédés d'utilisation
KR19980702833A (ko) 인간 헤르페스-바이러스-8을 치료하기 위한 펜시클로비르의 용도
JPH07188032A (ja) インフルエンザ治療薬
JPH04230322A (ja) 抗マラリア医薬組成物
MXPA98009596A (en) Use of azaspiran substituted in the treatment of a